Study on Optimizing the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual Disease

NCT07023588 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
70
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yehui Tan